Forty-three percent of melanoma patients have chronic complications from immunotherapies

(Vanderbilt University Medical Center) Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news